Received
Wednesday, March 30, 2022
Commodity
Botulinum Toxin Products and Processes for Manufacturing or Relating to Same
Investigation Number
337-TA-1313
Filed By
David Bilsker
Firm/Organization
Quinn Emanuel Urquhart & Sullivan LLP
Behalf Of
Medytox Inc.
Confidential
Yes
Country
None
Description
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, in the matter of certain botulinum toxin products and processes for manufacturing or relating to same. The proposed respondents are Hugel, Inc., Korea; Hugel America, Inc., Irvine, CA; and Croma Pharma GmbH, Austria.
Petition/Complaint Status
Instituted